Impact of polymorphisms of the genes encoding angiotensin II-forming enzymes on the progression of IgA nephropathy

Nephron - Clinical Practice

Volumn 118, Issue 2, 2011, Pages

  Jung, Eun Sook ^a   Kim, Sun Moon ^a   Cha, Ran Hui ^a   Oh, Yun Kyu ^a,b   Kim, Yon Su ^a   Kim, Suhnggwon ^a   Lim, Chun Soo ^a,b  

^a Seoul National University College of Medicine   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

Angiotensin II forming enzyme; Angiotensin converting enzyme; Chymase; Gene polymorphism; IgA nephropathy

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; CHYMASE;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HAZARD RATIO; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; ANGIOTENSIN II; ASIAN CONTINENTAL ANCESTRY GROUP; CHYMASES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GLOMERULONEPHRITIS, IGA; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RENIN; YOUNG ADULT;

EID: 78649798099     PISSN: 16602110     EISSN: 16602110     Source Type: Journal    
DOI: 10.1159/000321140     Document Type: Article

References (40)

1. Levy M, Berger J: Worldwide perspective of IgA nephropathy. Am J Kidney Dis 1988; 12: 340-347.
2. D'Amico G: The commonest glomerulonephritis in the world: IgA nephropathy. Q J Med 1987; 64: 709-727. (Pubitemid 18047151)
3. Donadio JV, Grande JP: IgA nephropathy. N Engl J Med 2002; 347: 738-748. (Pubitemid 35203906)
4. Galla JH: IgA nephropathy. Kidney Int 1995; 47: 377-387.
5. D'Amico G: Natural history of idiopathic IgA nephropathy: Role of clinical and histological prognostic factors. Am J Kidney Dis 2000; 36: 227-237. (Pubitemid 30485830)
6. Ibels LS, Gyory AZ: IgA nephropathy: Analysis of the natural history, important factors in the progression of renal disease, and a review of the literature. Medicine (Baltimore) 1994; 73: 79-102. (Pubitemid 24114627)
7. Radford MG Jr, Donadio JV Jr, Bergstralh EJ, Grande JP: Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 1997; 8: 199-207. (Pubitemid 127455874)
8. Hsu SI, Ramirez SB, Winn MP, Bonventre JV, Owen WF: Evidence for genetic factors in the development and progression of IgA nephropathy. Kidney Int 2000; 57: 1818-1835. (Pubitemid 30252274)
9. Scolari F, Amoroso A, Savoldi S, Mazzola G, Prati E, Valzorio B, Viola BF, Nicola B, Movilli E, Sandrini M, Campanini M, Maiorca R: Familial clustering of IgA nephropathy: Further evidence in an Italian population. Am J Kidney Dis 1999; 33: 857-865. (Pubitemid 29214681)
10. Hunley TE, Julian BA, Phillips JA 3rd, Summar ML, Yoshida H, Horn RG, Brown NJ, Fogo A, Ichikawa I, Kon V: Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 1996; 49: 571-577. (Pubitemid 26051837)
11. Narita I, Goto S, Saito N, Song J, Omori K, Kondo D, Sakatsume M, Gejyo F: Angiotensinogen gene variation and renoprotective efficacy of renin-angiotensin system blockade in IgA nephropathy. Kidney Int 2003; 64: 1050-1058. (Pubitemid 37013842)
12. Song J, Narita I, Goto S, Saito N, Omori K, Sato F, Ajiro J, Saga D, Kondo D, Sakatsume M, Gejyo F: Gender specific association of aldosterone synthase gene polymorphism with renal survival in patients with IgA nephropathy. J Med Genet 2003; 40: 372-376. (Pubitemid 36613478)
13. Remuzzi G, Perico N, Macia M, Ruggenenti P: The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease. Kidney Int 2005; 99(suppl):S57-S65.
14. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346. (Pubitemid 20370444)
15. Zhu X, Bouzekri N, Southam L, Cooper RS, Adeyemo A, McKenzie CA, Luke A, Chen G, Elston RC, Ward R: Linkage and association analysis of angiotensin I-converting enzyme (ACE)-gene polymorphisms with ACE concentration and blood pressure. Am J Hum Genet 2001; 68: 1139-1148. (Pubitemid 32424413)
16. Schena FP, D'Altri C, Cerullo G, Manno C, Gesualdo L: ACE gene polymorphism and IgA nephropathy: An ethnically homogeneous study and a meta-analysis. Kidney Int 2001; 60: 732-740. (Pubitemid 32678917)
17. Yong D, Qing WQ, Hua L, Kan JJ, Xi CJ, Jin QQ, Chao SH: Association of angiotensin Iconverting enzyme gene insertion/deletion polymorphism and IgA nephropathy: A meta- analysis. Am J Nephrol 2006; 26: 511-518. (Pubitemid 44971744)
18. Narita I, Goto S, Saito N, Song J, Omori K, Kondo D, Sakatsume M, Gejyo F: Renoprotective efficacy of renin-angiotensin inhibitors in IgA nephropathy is influenced by ACE A2350G polymorphism. J Med Genet 2003; 40:e130.
19. Arakawa K: Serine protease angiotensin II systems. J Hypertens 1996; 14(suppl):S3-S7. (Pubitemid 27051072)
20. Akasu M, Urata H, Kinoshita A, Sasaguri M, Ideishi M, Arakawa K: Differences in tissue angiotensin II-forming pathways by species and organs in vitro. Hypertension 1998; 32: 514-520. (Pubitemid 28429142)
21. Hollenberg NK, Fisher ND, Price DA: Pathways for angiotensin II generation in intact human tissue: Evidence from comparative pharmacological interruption of the renin system. Hypertension 1998; 32: 387-392. (Pubitemid 28429123)
22. Huang XR, Chen WY, Truong LD, Lan HY: Chymase is upregulated in diabetic nephropathy: Implications for an alternative pathway of angiotensin II-mediated diabetic renal and vascular disease. J Am Soc Nephrol 2003; 14: 1738-1747. (Pubitemid 36750469)
23. Ehara T, Shigematsu H: Contribution of mast cells to the tubulointerstitial lesions in IgA nephritis. Kidney Int 1998; 54: 1675-1683. (Pubitemid 28502910)
24. Miyake-Ogawa C, Miyazaki M, Abe K, Harada T, Ozono Y, Sakai H, Koji T, Kohno S: Tissue-specific expression of renin-angiotensin system components in IgA nephropathy. Am J Nephrol 2005; 25: 1-12. (Pubitemid 40529270)
25. Prasad P, Tiwari AK, Kumar KM, Ammini AC, Gupta A, Gupta R, Sharma AK, Rao AR, Nagendra R, Chandra TS, Tiwari SC, Rastogi P, Gupta BL, Thelma BK: Chronic renal insufficiency among Asian Indians with type 2 diabetes. I. Role of RAAS gene polymorphisms. BMC Med Genet 2006; 7: 42-50.
26. Lee HS, Lee MS, Lee SM, Lee SY, Lee ES, Lee EY, Park SY, Han JS, Kim S, Lee JS: Histological grading of IgA nephropathy predicting renal outcome: Revisiting H. S. Lee's glomerular grading system. Nephrol Dial Transplant 2005; 20: 342-348. (Pubitemid 40276890)
27. Lin MH, Tseng CH, Tseng CC, Huang CH, Chong CK, Tseng CP: Real-time PCR for rapid genotyping of angiotensin-converting enzyme insertion/deletion polymorphism. Clin Biochem 2001; 34: 661-666.
28. Kim SM, Chin HJ, Oh YK, Kim YS, Kim S, Lim CS: Blood pressure-related genes and the progression of IgA nephropathy. Nephron Clin Pract 2009; 113:c301-c308.
29. Costerousse O, Allegrini J, Lopez M, Alhenc- Gelas F: Angiotensin I-converting enzyme in human circulating mononuclear cells: Genetic polymorphism of expression in T-lymphocytes. Biochem J 1993; 290: 33-40. (Pubitemid 23081197)
30. Choung HJ, Yoon SR, Choi SK: Frequency of the angiotensin-converting enzyme (ACE) gene polymorphism in the general population and the elite endurance students in Korea. J Genet Med 1999; 3: 11-14.
31. Um JY, Kim HJ, Choi TJ, Jin CS, Park ST, Lee KC, Rhee HS, Lee KM, Lee YM, Kim HM, An NH, Kim JJ: Polymorphism of the angiotensin- converting enzyme gene in patients with cerebral infarction in Koreans. J Mol Neurosci 2001; 17: 279-283.
32. Yoshida H, Mitarai T, Kawamura T, Kitajima T, Miyazaki Y, Nagasawa R, Kawaguchi Y, Kubo H, Ichikawa I, Sakai O: Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 1995; 96: 2162-2169.
33. Chen X, Liu S, Ye Y, Xu Q: Association of angiotensin-converting enzyme gene insertion/ deletion polymorphism with the clinico- pathological manifestations in im munoglobulin A nephropathy patients. Chin Med J (Engl) 1997; 110: 526-529. (Pubitemid 127510188)
34. Maruyama K, Yoshida M, Nishio H, Shirakawa T, Kawamura T, Tanaka R, Nakamura H, Iijima K, Yoshikawa N: Polymorphisms of renin-angiotensin system genes in childhood IgA nephropathy. Pediatr Nephrol 2001; 16: 350-355. (Pubitemid 32366670)
35. Woo KT, Lau YK, Choong LH, Zhao Y, Tan HB, Fook-Chong S, Tan EK, Yap HK, Wong KS: Polymorphism of renin-angiotensin system genes in IgA nephropathy. Nephrology (Carlton) 2004; 9: 304-309. (Pubitemid 39576933)
36. Lau YK, Woo KT, Choong HL, Zhao Y, Tan HB, Cheung W, Yap HK: ACE gene polymorphism and disease progression of IgA nephropathy in Asians in Singapore. Nephron 2002; 91: 499-503. (Pubitemid 34765253)
37. Sayed-Tabatabaei FA, Oostra BA, Isaacs A, van Duijn CM, Witteman JC: ACE polymorphisms. Circ Res 2006; 98: 1123-1133. (Pubitemid 43948098)
38. Pfeufer A, Osterziel KJ, Urata H, Borck G, Schuster H, Wienker T, Dietz R, Luft FC: Angiotensin- converting enzyme and heart chymase gene polymorphisms in hypertrophic cardiomyopathy. Am J Cardiol 1996; 78: 362-364. (Pubitemid 26265286)
39. Ortlepp JR, Janssens U, Bleckmann F, Lauscher J, Merkelbach-Bruse S, Hanrath P, Hoffmann R: A chymase gene variant is associated with atherosclerosis in venous coronary artery bypass grafts. Coron Artery Dis 2001; 12: 493-497. (Pubitemid 32977819)
40. Zychma MJ, Zukowska-Szczechowska E, Lacka BI, Grzeszczak W: Angiotensinogen M235T and chymase gene CMA/B polymorphisms are not associated with nephropathy in type II diabetes. Nephrol Dial Transplant 2000; 15: 1965-1970.